Paulsen, Frank http://orcid.org/0000-0001-8836-528X
Bedke, Jens
Wegener, Daniel
Marzec, Jolanta
Martus, Peter
Nann, Dominik
Stenzl, Arnulf
Zips, Daniel
Müller, Arndt-Christian
Funding for this research was provided by:
Eberhard Karls Universität Tübingen
Article History
Received: 14 March 2021
Accepted: 9 August 2021
First Online: 2 September 2021
Conflict of interest
: D. Wegener, D. Zips, and A.-C. Müller mention the cooperation with Siemens Healthcare, Philips, Elekta, and PTW Freiburg in a research project. J. Bedke is member of advisory boards/consultant for Ipsen Pharma, Roche, Bristol-Myers Squibb, EUSA, Eisai, MSD, Pfizer. J. Bedke is member of advisory boards/consultant for Ipsen Pharma, Roche, Bristol-Myers Squibb, EUSA, Eisai, MSD, Pfizer. A. Stenzl receives honoraria as speaker for Janssen, Ipsen Pharma, Roche, MSD, Eisai, EUSA, Bristol-Myers Squibb. A. Stenzl is member of advisory boards/consultant for Ipsen Pharma, Roche, Janssen, Alere, Bristol-Myers Squibb, Stebabiotech, Synergo, Ferring. A. Stenzl mentions research grants from Amgen Inc, immatics biotechnologies GmbH, Novartis AG, and Karl Storz AG. A. Stenzl receives honoraria as speaker for Janssen, Ipsen Pharma, Sanofi Aventis, CureVac, Astellas. A. Stenzl mentions Institutional fees for clinical studies by Bayer AG, Calithera, Cepheid, CureVac, Eisai, GemeDx Biosciences, immatics biotechnologies GmbH, Johnson & Johnson, MSD, Novartis, Pfizer, Roche. F. Paulsen, J. Marzec, P. Martus, and D. Nann declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards as published data were used for the development of a theoretical model, also regarding informed consent.